In summary, based on bulk and scRNA-seq analysis, this study revealed eight prognostic gene signatures related to FGFBP2+ NK cell in HCC, which were utilized to create a RiskScore model. The gene discussed is FGFBP2; the disease is hepatocellular carcinoma.